The global Rabies Vaccine market is projected to reach US$ 1229.1 million by 2030 from an estimated US$ 971.4 million in 2024, at a CAGR of 4.0% during 2024 and 2030.

Rabies Vaccine Market

Rabies vaccine is an active immunizing agent used to prevent infection caused by the rabies virus. The vaccine works by causing your body to produce its own protection (antibodies) against the rabies virus.

Global Rabies Vaccine key players include Chengda, Changsheng, Prcmise, VACN, etc. Global top four manufacturers hold a share about 70%.

China is the largest market, with a share about 85%, followed by Europe, and North America, both have a share over 10 percent.

In terms of product, Vero Cell Rabies Vaccine is the largest segment, with a share over 75%. And in terms of application, the largest application is Post-exposure Prophylaxis, followed by Pre-exposure Prophylaxis.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Rabies Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyse their position in the current marketplace, and make informed business decisions regarding Rabies Vaccine.

The Rabies Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Rabies Vaccine market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Rabies Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application, and regions.

Market Segmentation

Scope of Rabies Vaccine Market Report

Report Metric	Details
Report Name	Rabies Vaccine Market
Accounted market size in 2024	an estimated US$ 971.4 million
Forecasted market size in 2030	US$ 1229.1 million
CAGR	4.0%
Base Year	2024
Forecasted years	2024 - 2030
Segment by Type	Vero Cell Rabies Vaccine BHK Chick Embryo Cell Rabies Vaccine Others
Segment by Application	Pre-exposure Prophylaxis Post-exposure Prophylaxis
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	GSK (Novartis), Sanofi-Pasteur, Chengda, Yisheng, Prcmise, VACN, Changsheng, BCHT, Hissen
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Rabies Vaccine in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3: Detailed analysis of Rabies Vaccine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Rabies Vaccine sales, revenue, price, gross margin, sales by region, by Type, by Application, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: APAC by Type, by Application and by country, sales, and revenue for each segment.
Chapter 9: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 10: Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Middle East and Africa by Type, by Application and by country, sales, and revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion.

FAQ for this report

How fast is Rabies Vaccine Market growing?

Ans: The Rabies Vaccine Market witnessing a CAGR of 4.0% during the forecast period 2024-2030.

What is the Rabies Vaccine Market size in 2030?

Ans: The Rabies Vaccine Market size in 2030 will be US$ 1229.1 million.

What is the market share of major companies in Rabies Vaccine Market?

Ans: Global top four manufacturers hold a share about 70%.

What is the Rabies Vaccine Market share by type?

Ans: In terms of product, Vero Cell Rabies Vaccine is the largest segment, with a share over 75%.

Who are the main players in the Rabies Vaccine Market report?

Ans: The main players in the Rabies Vaccine Market are GSK (Novartis), Sanofi-Pasteur, Chengda, Yisheng, Prcmise, VACN, Changsheng, BCHT, Hissen

What are the Application segmentation covered in the Rabies Vaccine Market report?

Ans: The Applications covered in the Rabies Vaccine Market report are Pre-exposure Prophylaxis, Post-exposure Prophylaxis

What are the Type segmentation covered in the Rabies Vaccine Market report?

Ans: The Types covered in the Rabies Vaccine Market report are Vero Cell Rabies Vaccine, BHK, Chick Embryo Cell Rabies Vaccine, Others

1 Study Coverage

1.1 Rabies Vaccine Product Introduction

1.2 Market by Type

1.2.1 Global Rabies Vaccine Market Size Growth Rate by Type (2019 VS 2023 VS 2030)

1.2.2 Vero Cell Rabies Vaccine

1.2.3 BHK

1.2.4 Chick Embryo Cell Rabies Vaccine

1.2.5 Others

1.3 Market by Application

1.3.1 Global Rabies Vaccine Market Size Growth Rate by Application (2019 VS 2023 VS 2030)

1.3.2 Pre-exposure Prophylaxis

1.3.3 Post-exposure Prophylaxis

1.4 Study Objectives

1.5 Years Considered

2 Executive Summary

2.1 Global Rabies Vaccine Market Size Estimates and Forecasts

2.1.1 Global Rabies Vaccine Revenue 2019-2030

2.1.2 Global Rabies Vaccine Sales 2019-2030

2.2 Rabies Vaccine Market Size by Region: 2023 Versus 2030

2.3 Rabies Vaccine Sales by Region (2019-2030)

2.3.1 Global Rabies Vaccine Sales by Region: 2019-2024

2.3.2 Global Rabies Vaccine Sales Forecast by Region (2025-2030)

2.3.3 Global Rabies Vaccine Sales Market Share by Region (2019-2030)

2.4 Rabies Vaccine Market Estimates and Projections by Region (2025-2030)

2.4.1 Global Rabies Vaccine Revenue by Region: 2019-2024

2.4.2 Global Rabies Vaccine Revenue Forecast by Region (2025-2030)

2.4.3 Global Rabies Vaccine Revenue Market Share by Region (2019-2030)

3 Global Rabies Vaccine by Manufacturers

3.1 Global Top Rabies Vaccine Manufacturers by Sales

3.1.1 Global Rabies Vaccine Sales by Manufacturer (2019-2024)

3.1.2 Global Rabies Vaccine Sales Market Share by Manufacturer (2019-2024)

3.2 Global Top Rabies Vaccine Manufacturers by Revenue

3.2.1 Global Rabies Vaccine Revenue by Manufacturer (2019-2024)

3.2.2 Global Rabies Vaccine Revenue Share by Manufacturer (2019-2024)

3.3 Global Rabies Vaccine Price by Manufacturer (2019-2024)

3.4 Competitive Landscape

3.4.1 Key Rabies Vaccine Manufacturers Covered: Ranking by Revenue

3.4.2 Global Rabies Vaccine Market Concentration Ratio (CR5 and HHI) & (2019-2024)

3.4.3 Global Rabies Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

3.5 Global Rabies Vaccine Manufacturing Base Distribution, Product Type

3.5.1 Rabies Vaccine Manufacturers Manufacturing Base Distribution, Headquarters

3.5.2 Manufacturers Rabies Vaccine Product Type

3.5.3 Date of International Manufacturers Enter into Rabies Vaccine Market

3.6 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Company Profiles

4.1 GSK (Novartis)

4.1.1 GSK (Novartis) Company Information

4.1.2 GSK (Novartis) Description, Business Overview

4.1.3 GSK (Novartis) Rabies Vaccine Products Offered

4.1.4 GSK (Novartis) Rabies Vaccine Sales, Revenue and Gross Margin (2019-2024)

4.1.5 GSK (Novartis) Rabies Vaccine Sales by Product in 2023

4.1.6 GSK (Novartis) Rabies Vaccine Sales by Application in 2023

4.1.7 GSK (Novartis) Rabies Vaccine Sales by Geographic Area in 2023

4.1.8 GSK (Novartis) Recent Developments

4.2 Sanofi-Pasteur

4.2.1 Sanofi-Pasteur Company Information

4.2.2 Sanofi-Pasteur Description, Business Overview

4.2.3 Sanofi-Pasteur Rabies Vaccine Products Offered

4.2.4 Sanofi-Pasteur Rabies Vaccine Sales, Revenue and Gross Margin (2019-2024)

4.2.5 Sanofi-Pasteur Rabies Vaccine Sales by Product in 2023

4.2.6 Sanofi-Pasteur Rabies Vaccine Sales by Application in 2023

4.2.7 Sanofi-Pasteur Rabies Vaccine Sales by Geographic Area in 2023

4.2.8 Sanofi-Pasteur Recent Developments

4.3 Chengda

4.3.1 Chengda Company Information

4.3.2 Chengda Description, Business Overview

4.3.3 Chengda Rabies Vaccine Products Offered

4.3.4 Chengda Rabies Vaccine Sales, Revenue and Gross Margin (2019-2024)

4.3.5 Chengda Rabies Vaccine Sales by Product in 2023

4.3.6 Chengda Rabies Vaccine Sales by Application in 2023

4.3.7 Chengda Rabies Vaccine Sales by Geographic Area in 2023

4.3.8 Chengda Recent Developments

4.4 Yisheng

4.4.1 Yisheng Company Information

4.4.2 Yisheng Description, Business Overview

4.4.3 Yisheng Rabies Vaccine Products Offered

4.4.4 Yisheng Rabies Vaccine Sales, Revenue and Gross Margin (2019-2024)

4.4.5 Yisheng Rabies Vaccine Sales by Product in 2023

4.4.6 Yisheng Rabies Vaccine Sales by Application in 2023

4.4.7 Yisheng Rabies Vaccine Sales by Geographic Area in 2023

4.4.8 Yisheng Recent Developments

4.5 Prcmise

4.5.1 Prcmise Company Information

4.5.2 Prcmise Description, Business Overview

4.5.3 Prcmise Rabies Vaccine Products Offered

4.5.4 Prcmise Rabies Vaccine Sales, Revenue and Gross Margin (2019-2024)

4.5.5 Prcmise Rabies Vaccine Sales by Product in 2023

4.5.6 Prcmise Rabies Vaccine Sales by Application in 2023

4.5.7 Prcmise Rabies Vaccine Sales by Geographic Area in 2023

4.5.8 Prcmise Recent Developments

4.6 VACN

4.6.1 VACN Company Information

4.6.2 VACN Description, Business Overview

4.6.3 VACN Rabies Vaccine Products Offered

4.6.4 VACN Rabies Vaccine Sales, Revenue and Gross Margin (2019-2024)

4.6.5 VACN Rabies Vaccine Sales by Product in 2023

4.6.6 VACN Rabies Vaccine Sales by Application in 2023

4.6.7 VACN Rabies Vaccine Sales by Geographic Area in 2023

4.6.8 VACN Recent Development

4.7 Changsheng

4.7.1 Changsheng Company Information

4.7.2 Changsheng Description, Business Overview

4.7.3 Changsheng Rabies Vaccine Products Offered

4.7.4 Changsheng Rabies Vaccine Sales, Revenue and Gross Margin (2019-2024)

4.7.5 Changsheng Rabies Vaccine Sales by Product in 2023

4.7.6 Changsheng Rabies Vaccine Sales by Application in 2023

4.7.7 Changsheng Rabies Vaccine Sales by Geographic Area in 2023

4.7.8 Changsheng Recent Development

4.8 BCHT

4.8.1 BCHT Company Information

4.8.2 BCHT Description, Business Overview

4.8.3 BCHT Rabies Vaccine Products Offered

4.8.4 BCHT Rabies Vaccine Sales, Revenue and Gross Margin (2019-2024)

4.8.5 BCHT Rabies Vaccine Sales by Product in 2023

4.8.6 BCHT Rabies Vaccine Sales by Application in 2023

4.8.7 BCHT Rabies Vaccine Sales by Geographic Area in 2023

4.8.8 BCHT Recent Development

4.9 Hissen

4.9.1 Hissen Company Information

4.9.2 Hissen Description, Business Overview

4.9.3 Hissen Rabies Vaccine Products Offered

4.9.4 Hissen Rabies Vaccine Sales, Revenue and Gross Margin (2019-2024)

4.9.5 Hissen Rabies Vaccine Sales by Product in 2023

4.9.6 Hissen Rabies Vaccine Sales by Application in 2023

4.9.7 Hissen Rabies Vaccine Sales by Geographic Area in 2023

4.9.8 Hissen Recent Development

5 Breakdown Data by Type

5.1 Global Rabies Vaccine Sales by Type (2019-2030)

5.1.1 Global Rabies Vaccine Sales by Type (2019-2024)

5.1.2 Global Rabies Vaccine Sales Forecast by Type (2025-2030)

5.1.3 Global Rabies Vaccine Sales Market Share by Type (2019-2030)

5.2 Global Rabies Vaccine Revenue Forecast by Type (2019-2030)

5.2.1 Global Rabies Vaccine Revenue by Type (2019-2024)

5.2.2 Global Rabies Vaccine Revenue Forecast by Type (2025-2030)

5.2.3 Global Rabies Vaccine Revenue Market Share by Type (2019-2030)

5.3 Rabies Vaccine Average Selling Price (ASP) by Type (2019-2030)

6 Breakdown Data by Application

6.1 Global Rabies Vaccine Sales by Application (2019-2030)

6.1.1 Global Rabies Vaccine Sales by Application (2019-2024)

6.1.2 Global Rabies Vaccine Sales Forecast by Application (2025-2030)

6.1.3 Global Rabies Vaccine Sales Market Share by Application (2019-2030)

6.2 Global Rabies Vaccine Revenue Forecast by Application (2019-2030)

6.2.1 Global Rabies Vaccine Revenue by Application (2019-2024)

6.2.2 Global Rabies Vaccine Revenue Forecast by Application (2025-2030)

6.2.3 Global Rabies Vaccine Revenue Market Share by Application (2019-2030)

6.3 Rabies Vaccine Average Selling Price (ASP) by Application (2019-2030)

7 North America

7.1 North America Rabies Vaccine Market Size YoY Growth 2019-2030

7.2 North America Rabies Vaccine Market Facts & Figures by Country

7.2.1 North America Rabies Vaccine Sales by Country (2019-2030)

7.2.2 North America Rabies Vaccine Revenue by Country (2019-2030)

7.3 North America Rabies Vaccine Sales by Type (2019-2024)

7.4 North America Rabies Vaccine Sales by Application (2019-2024)

8 Asia-Pacific

8.1 Asia-Pacific Rabies Vaccine Market Size YoY Growth 2019-2030

8.2 Asia-Pacific Rabies Vaccine Market Facts & Figures by Region

8.2.1 Asia-Pacific Rabies Vaccine Sales by Region (2019-2030)

8.2.2 Asia-Pacific Rabies Vaccine Revenue by Region (2019-2030)

8.3 Asia-Pacific Rabies Vaccine Sales by Type (2019-2024)

8.4 Asia-Pacific Rabies Vaccine Sales by Application (2019-2024)

9 Europe

9.1 Europe Rabies Vaccine Market Size YoY Growth 2019-2030

9.2 Europe Rabies Vaccine Market Facts & Figures by Country

9.2.1 Europe Rabies Vaccine Sales by Country (2019-2030)

9.2.2 Europe Rabies Vaccine Revenue by Country (2019-2030)

9.3 Europe Rabies Vaccine Sales by Type (2019-2024)

9.4 Europe Rabies Vaccine Sales by Application (2019-2024)

10 Latin America

10.1 Latin America Rabies Vaccine Market Size YoY Growth 2019-2030

10.2 Latin America Rabies Vaccine Market Facts & Figures by Country

10.2.1 Latin America Rabies Vaccine Sales by Country (2019-2030)

10.2.2 Latin America Rabies Vaccine Revenue by Country (2019-2030)

10.3 Latin America Rabies Vaccine Sales by Type (2019-2024)

10.4 Latin America Rabies Vaccine Sales by Application (2019-2024)

11 Middle East and Africa

11.1 Middle East and Africa Rabies Vaccine Market Size YoY Growth 2019-2030

11.2 Middle East and Africa Rabies Vaccine Market Facts & Figures by Country

11.2.1 Middle East and Africa Rabies Vaccine Sales by Country (2019-2030)

11.2.2 Middle East and Africa Rabies Vaccine Revenue by Country (2019-2030)

11.3 Middle East and Africa Rabies Vaccine Sales by Type (2019-2024)

11.4 Middle East and Africa Rabies Vaccine Sales by Application (2019-2024)

12 Supply Chain and Sales Channel Analysis

12.1 Rabies Vaccine Supply Chain Analysis

12.2 Rabies Vaccine Key Raw Materials and Upstream Suppliers

12.3 Rabies Vaccine Clients Analysis

12.4 Rabies Vaccine Sales Channel and Sales Model Analysis

12.4.1 Rabies Vaccine Distribution Channel Analysis: Indirect Sales VS Direct Sales

12.4.2 Rabies Vaccine Distribution Channel Analysis: Online Sales VS Offline Sales

12.4.3 Rabies Vaccine Distributors

13 Market Dynamics

13.1 Rabies Vaccine Industry Trends

13.2 Rabies Vaccine Market Drivers

13.3 Rabies Vaccine Market Challenges

13.4 Rabies Vaccine Market Restraints

14 Research Findings and Conclusion

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.2 Data Source

15.2 Author Details

15.3 Disclaimer

FEATURED COMPANIES

List of Tables

Table 1. Global Rabies Vaccine Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Major Manufacturers of Vero Cell Rabies Vaccine

Table 3. Major Manufacturers of BHK

Table 4. Major Manufacturers of Chick Embryo Cell Rabies Vaccine

Table 5. Major Manufacturers of Others

Table 6. Global Rabies Vaccine Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 7. Global Rabies Vaccine Market Size by Region (US$ Million): 2023 VS 2030

Table 8. Global Rabies Vaccine Sales by Region (2019-2024) & (K Units)

Table 9. Global Rabies Vaccine Sales Forecast by Region (2025-2030) & (K Units)

Table 10. Global Rabies Vaccine Revenue by Region (2019-2024) & (US$ Million)

Table 11. Global Rabies Vaccine Revenue Forecast by Region (2025-2030) & (US$ Million)

Table 12. Global Rabies Vaccine Sales by Manufacturer (2019-2024) & (K Units)

Table 13. Global Rabies Vaccine Sales Share by Manufacturer (2019-2024)

Table 14. Rabies Vaccine Revenue by Manufacturer (2019-2024) & (US$ Million)

Table 15. Rabies Vaccine Revenue Share by Manufacturer (2019-2024)

Table 16. Key Manufacturers Rabies Vaccine Price (2019-2024) & (USD/Unit)

Table 17. Ranking of Global Top Rabies Vaccine Manufacturers by Revenue (US$ Million) in 2023

Table 18. Global Rabies Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI) & (2019-2024)

Table 19. Global Rabies Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Rabies Vaccine as of 2023)

Table 20. Rabies Vaccine Manufacturers Manufacturing Base Distribution and Headquarters

Table 21. Manufacturers Rabies Vaccine Product Type

Table 22. Date of International Manufacturers Enter into Rabies Vaccine Market

Table 23. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 24. GSK (Novartis) Company Information

Table 25. GSK (Novartis) Description and Business Overview

Table 26. GSK (Novartis) Rabies Vaccine Product

Table 27. GSK (Novartis) Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 28. GSK (Novartis) Sales Proportion of Rabies Vaccine by Product in 2023

Table 29. GSK (Novartis) Sales Proportion of Rabies Vaccine by Application in 2023

Table 30. GSK (Novartis) Sales Proportion of Rabies Vaccine by Geographic Area in 2023

Table 31. GSK (Novartis) Recent Development

Table 32. Sanofi-Pasteur Company Information

Table 33. Sanofi-Pasteur Description and Business Overview

Table 34. Sanofi-Pasteur Rabies Vaccine Product

Table 35. Sanofi-Pasteur Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 36. Sanofi-Pasteur Sales Proportion of Rabies Vaccine by Product in 2023

Table 37. Sanofi-Pasteur Sales Proportion of Rabies Vaccine by Application in 2023

Table 38. Sanofi-Pasteur Sales Proportion of Rabies Vaccine by Geographic Area in 2023

Table 39. Sanofi-Pasteur Recent Development

Table 40. Chengda Company Information

Table 41. Chengda Description and Business Overview

Table 42. Chengda Rabies Vaccine Product

Table 43. Chengda Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 44. Chengda Sales Proportion of Rabies Vaccine by Product in 2023

Table 45. Chengda Sales Proportion of Rabies Vaccine by Application in 2023

Table 46. Chengda Sales Proportion of Rabies Vaccine by Geographic Area in 2023

Table 47. Chengda Recent Development

Table 48. Yisheng Company Information

Table 49. Yisheng Description and Business Overview

Table 50. Yisheng Rabies Vaccine Product

Table 51. Yisheng Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 52. Yisheng Sales Proportion of Rabies Vaccine by Product in 2023

Table 53. Yisheng Sales Proportion of Rabies Vaccine by Application in 2023

Table 54. Yisheng Sales Proportion of Rabies Vaccine by Geographic Area in 2023

Table 55. Yisheng Recent Development

Table 56. Prcmise Company Information

Table 57. Prcmise Description and Business Overview

Table 58. Prcmise Rabies Vaccine Product

Table 59. Prcmise Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 60. Prcmise Sales Proportion of Rabies Vaccine by Product in 2023

Table 61. Prcmise Sales Proportion of Rabies Vaccine by Application in 2023

Table 62. Prcmise Sales Proportion of Rabies Vaccine by Geographic Area in 2023

Table 63. Prcmise Recent Development

Table 64. VACN Company Information

Table 65. VACN Description and Business Overview

Table 66. VACN Rabies Vaccine Product

Table 67. VACN Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 68. VACN Sales Proportion of Rabies Vaccine by Product in 2023

Table 69. VACN Sales Proportion of Rabies Vaccine by Application in 2023

Table 70. VACN Sales Proportion of Rabies Vaccine by Geographic Area in 2023

Table 71. VACN Recent Development

Table 72. Changsheng Company Information

Table 73. Changsheng Description and Business Overview

Table 74. Changsheng Rabies Vaccine Product

Table 75. Changsheng Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 76. Changsheng Sales Proportion of Rabies Vaccine by Product in 2023

Table 77. Changsheng Sales Proportion of Rabies Vaccine by Application in 2023

Table 78. Changsheng Sales Proportion of Rabies Vaccine by Geographic Area in 2023

Table 79. Changsheng Recent Development

Table 80. BCHT Company Information

Table 81. BCHT Description and Business Overview

Table 82. BCHT Rabies Vaccine Product

Table 83. BCHT Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 84. BCHT Sales Proportion of Rabies Vaccine by Product in 2023

Table 85. BCHT Sales Proportion of Rabies Vaccine by Application in 2023

Table 86. BCHT Sales Proportion of Rabies Vaccine by Geographic Area in 2023

Table 87. BCHT Recent Development

Table 88. Hissen Company Information

Table 89. Hissen Description and Business Overview

Table 90. Hissen Rabies Vaccine Product

Table 91. Hissen Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 92. Hissen Sales Proportion of Rabies Vaccine by Product in 2023

Table 93. Hissen Sales Proportion of Rabies Vaccine by Application in 2023

Table 94. Hissen Sales Proportion of Rabies Vaccine by Geographic Area in 2023

Table 95. Hissen Recent Development

Table 96. Global Rabies Vaccine Sales by Type (2019-2024) & (K Units)

Table 97. Global Rabies Vaccine Sales Forecast by Type (2025-2030) & (K Units)

Table 98. Global Rabies Vaccine Revenue by Type (2019-2024) & (US$ Million)

Table 99. Global Rabies Vaccine Revenue Forecast by Type (2025-2030) & (US$ Million)

Table 100. Global Rabies Vaccine Sales by Application (2019-2024) & (K Units)

Table 101. Global Rabies Vaccine Sales Forecast by Application (2025-2030) & (K Units)

Table 102. Global Rabies Vaccine Revenue by Application (2019-2024) & (US$ Million)

Table 103. Global Rabies Vaccine Revenue Forecast by Application (2025-2030) & (US$ Million)

Table 104. North America Rabies Vaccine Sales by Country (2019-2024) & (K Units)

Table 105. North America Rabies Vaccine Sales by Country (2025-2030) & (K Units)

Table 106. North America Rabies Vaccine Revenue by Country (2019-2024) & (US$ Million)

Table 107. North America Rabies Vaccine Revenue by Country (2025-2030) & (US$ Million)

Table 108. North America Rabies Vaccine Sales by Type (2019-2024) & (K Units)

Table 109. North America Rabies Vaccine Sales by Application (2019-2024) & (K Units)

Table 110. Asia-Pacific Rabies Vaccine Sales by Region (2019-2024) & (K Units)

Table 111. Asia-Pacific Rabies Vaccine Sales by Region (2025-2030) & (K Units)

Table 112. Asia-Pacific Rabies Vaccine Revenue by Region (2019-2030) & (US$ Million)

Table 113. Asia-Pacific Rabies Vaccine Revenue by Region (2025-2030) & (US$ Million)

Table 114. Asia-Pacific Rabies Vaccine Sales by Type (2019-2024) & (K Units)

Table 115. Asia-Pacific Rabies Vaccine Sales by Application (2019-2024) & (K Units)

Table 116. Europe Rabies Vaccine Sales by Country (2019-2024) & (K Units)

Table 117. Europe Rabies Vaccine Sales by Country (2025-2030) & (K Units)

Table 118. Europe Rabies Vaccine Revenue by Country (2019-2024) & (US$ Million)

Table 119. Europe Rabies Vaccine Revenue by Country (2025-2030) & (US$ Million)

Table 120. Europe Rabies Vaccine Sales by Type (2019-2024) & (K Units)

Table 121. Europe Rabies Vaccine Sales by Application (2019-2024) & (K Units)

Table 122. Latin America Rabies Vaccine Sales by Country (2019-2024) & (K Units)

Table 123. Latin America Rabies Vaccine Sales by Country (2025-2030) & (K Units)

Table 124. Latin America Rabies Vaccine Revenue by Country (2019-2024) & (US$ Million)

Table 125. Latin America Rabies Vaccine Revenue by Country (2025-2030) & (US$ Million)

Table 126. Latin America Rabies Vaccine Sales by Type (2019-2024) & (K Units)

Table 127. Latin America Rabies Vaccine Sales by Application (2019-2024) & (K Units)

Table 128. Middle East and Africa Rabies Vaccine Sales by Country (2019-2024) & (K Units)

Table 129. Middle East and Africa Rabies Vaccine Sales by Country (2025-2030) & (K Units)

Table 130. Middle East and Africa Rabies Vaccine Revenue by Country (2019-2024) & (US$ Million)

Table 131. Middle East and Africa Rabies Vaccine Revenue by Country (2025-2030) & (US$ Million)

Table 132. Middle East and Africa Rabies Vaccine Sales by Type (2019-2024) & (K Units)

Table 133. Middle East and Africa Rabies Vaccine Sales by Application (2019-2024) & (K Units)

Table 134. Rabies Vaccine Key Raw Materials, Industry Status and Trend

Table 135. Rabies Vaccine Key Raw Materials and Upstream Suppliers

Table 136. Rabies Vaccine Clients Status and Trend

Table 137. Rabies Vaccine Typical Clients

Table 138. Rabies Vaccine Distributors

Table 139. Rabies Vaccine Market Trends

Table 140. Rabies Vaccine Market Drivers

Table 141. Rabies Vaccine Market Challenges

Table 142. Rabies Vaccine Market Restraints

Table 143. Research Programs/Design for This Report

Table 144. Key Data Information from Secondary Sources

Table 145. Key Data Information from Primary Sources

List of Figures

Figure 1. Rabies Vaccine Product Picture

Figure 2. Global Rabies Vaccine Sales Market Share by Type in 2023 & 2030

Figure 3. Vero Cell Rabies Vaccine Product Picture

Figure 4. BHK Product Picture

Figure 5. Chick Embryo Cell Rabies Vaccine Product Picture

Figure 6. Others Product Picture

Figure 7. Global Rabies Vaccine Sales Market Share by Application in 2023 & 2030

Figure 8. Pre-exposure Prophylaxis Examples

Figure 9. Post-exposure Prophylaxis Examples

Figure 10. Rabies Vaccine Report Years Considered

Figure 11. Global Rabies Vaccine Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 12. Global Rabies Vaccine Market Size 2019-2030 (US$ Million)

Figure 13. Global Rabies Vaccine Sales 2019-2030 (K Units)

Figure 14. Global Rabies Vaccine Sales Market Share Forecast by Region (2019-2030)

Figure 15. Global Rabies Vaccine Revenue Market Share by Region (2019-2030)

Figure 16. Global Rabies Vaccine Sales Share by Manufacturer in 2023

Figure 17. Rabies Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023

Figure 18. Global Rabies Vaccine Sales Market Share Forecast by Type (2019-2030)

Figure 19. Global Rabies Vaccine Revenue Market Share Forecast by Type (2019-2030)

Figure 20. Rabies Vaccine Average Selling Price (ASP) by Type (2019-2024) & (USD/Unit)

Figure 21. Global Rabies Vaccine Sales Market Share Forecast by Application (2019-2030)

Figure 22. Global Rabies Vaccine Revenue Market Share Forecast by Application (2019-2030)

Figure 23. Rabies Vaccine Average Selling Price (ASP) by Application (2019-2024) & (USD/Unit)

Figure 24. North America Rabies Vaccine Revenue 2019-2030 (US$ Million)

Figure 25. North America Rabies Vaccine Sales Market Share by Type (2019-2024)

Figure 26. North America Rabies Vaccine Sales Market Share by Application (2019-2024)

Figure 27. Asia-Pacific Rabies Vaccine Revenue 2019-2030 (US$ Million)

Figure 28. Asia-Pacific Rabies Vaccine Sales Market Share by Region (2019-2030)

Figure 29. Asia-Pacific Rabies Vaccine Revenue Market Share by Region (2019-2030)

Figure 30. Asia-Pacific Rabies Vaccine Sales Market Share by Type (2019-2024)

Figure 31. Asia-Pacific Rabies Vaccine Sales Market Share by Application (2019-2024)

Figure 32. Europe Rabies Vaccine Revenue Growth Rate 2019-2030 (US$ Million)

Figure 33. Europe Rabies Vaccine Sales Market Share by Country (2019-2030)

Figure 34. Europe Rabies Vaccine Revenue Market Share by Country (2019-2030)

Figure 35. Europe Rabies Vaccine Sales Market Share by Type (2019-2024)

Figure 36. Europe Rabies Vaccine Sales Market Share by Application (2019-2024)

Figure 37. Latin America Rabies Vaccine Revenue Growth Rate 2019-2030 (US$ Million)

Figure 38. Latin America Rabies Vaccine Sales Market Share by Country (2019-2030)

Figure 39. Latin America Rabies Vaccine Revenue Market Share by Country (2019-2024)

Figure 40. Latin America Rabies Vaccine Sales Market Share by Type (2019-2024)

Figure 41. Latin America Rabies Vaccine Sales Market Share by Application (2019-2024)

Figure 42. Middle East and Africa Rabies Vaccine Revenue Growth Rate 2019-2030 (US$ Million)

Figure 43. Middle East and Africa Rabies Vaccine Sales Market Share by Country (2019-2030)

Figure 44. Middle East and Africa Rabies Vaccine Revenue Market Share by Country (2019-2030)

Figure 45. Middle East and Africa Rabies Vaccine Sales Market Share by Type (2019-2024)

Figure 46. Middle East and Africa Rabies Vaccine Sales Market Share by Application (2019-2024)

Figure 47. Rabies Vaccine Supply Chain (Upstream and Downstream Market)

Figure 48. Global Production Market Share of Rabies Vaccine Raw Materials by Region in 2023

Figure 49. Rabies Vaccine Distribution Channels

Figure 50. Global Rabies Vaccine Percentage 2019-2030: Indirect Sales VS Direct Sales

Figure 51. Global Rabies Vaccine Percentage 2019-2030: Online Sales VS Offline Sales

Figure 52. Bottom-up and Top-down Approaches for This Report

Figure 53. Data Triangulation

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$5900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$8850

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$11800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions